Fairmount Funds Management LLC

Average Profitability
34.73%
Insider Buys Quantity
6
Insider Buys Sum
$119.5M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Fairmount Funds Management LLC

According to the SEC Form 4 filings, Fairmount Funds Management LLC, being in a position of

  1. at Viridian Therapeutics, Inc.,
    оver the last 12 months, has bought 2076190 shares for $40M, and sold 0 shares,
    over all time since 2021-09-21, has bought 2985190 shares for $50M, and sold 0 shares.

The largest purchase of all time was on 2023-07-13 and amounted to 2941176 shares of Apogee Therapeutics, Inc. for $50M.

Biography of Fairmount Funds Management LLC

No biography is available at this moment.

2024-09-13PurchaseViridian Therapeutics, Inc.
VRDN
1.6M
2.1285%
$18.75$30M+0.5%
2024-01-22PurchaseViridian Therapeutics, Inc.
VRDN
See Remarks
476,190
0.9578%
$21.00$10M-11.63%
2023-07-13PurchaseApogee Therapeutics, Inc.
APGE
director
2.94M
1.8926%
$17.00$50M+50.02%
2023-06-09PurchaseCogent Biosciences, Inc.
COGT
10 percent owner
800,000
0.9139%
$12.00$9.6M-33.6%
2022-06-16PurchaseCogent Biosciences, Inc.
COGT
1.2M
0.9424%
$8.25$9.9M+55.51%
2021-09-21PurchaseViridian Therapeutics, Inc.
VRDN
909,000
7.0902%
$11.00$10M+43.22%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.